229 related articles for article (PubMed ID: 34687005)
1. Effect of Cannabidiol on Interictal Epileptiform Activity and Sleep Architecture in Children with Intractable Epilepsy: A Prospective Open-Label Study.
Klotz KA; Grob D; Schönberger J; Nakamura L; Metternich B; Schulze-Bonhage A; Jacobs J
CNS Drugs; 2021 Nov; 35(11):1207-1215. PubMed ID: 34687005
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
[TBL] [Abstract][Full Text] [Related]
3. The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study.
Mitelpunkt A; Kramer U; Hausman Kedem M; Zilbershot Fink E; Orbach R; Chernuha V; Fattal-Valevski A; Deutsch L; Heffetz D; Sacks H
Epilepsy Behav; 2019 Sep; 98(Pt A):233-237. PubMed ID: 31394352
[TBL] [Abstract][Full Text] [Related]
4. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
[TBL] [Abstract][Full Text] [Related]
5. Effect of partial drug withdrawal on the lateralization of interictal epileptiform discharges and its relationship to surgical outcome in patients with hippocampal sclerosis.
Doležalová I; Brázdil M; Hermanová M; Janoušová E; Kuba R
Epilepsy Res; 2014 Oct; 108(8):1406-16. PubMed ID: 25052709
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
Laux LC; Bebin EM; Checketts D; Chez M; Flamini R; Marsh ED; Miller I; Nichol K; Park Y; Segal E; Seltzer L; Szaflarski JP; Thiele EA; Weinstock A;
Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
[TBL] [Abstract][Full Text] [Related]
7. NREM Sleep and Antiepileptic Medications Modulate Epileptiform Activity by Altering Cortical Synchrony.
Nayak CS; Mariyappa N; Majumdar KK; Ravi GS; Prasad PD; Nagappa M; Kandavel T; Taly AB; Sinha S
Clin EEG Neurosci; 2018 Nov; 49(6):417-424. PubMed ID: 29308656
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy.
Grayson L; Ampah S; Hernando K; Kankirawatana P; Gaston T; Cutter G; Szaflarski JP; Martina Bebin E;
Epilepsy Behav; 2021 Sep; 122():108190. PubMed ID: 34273739
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy.
Wheless JW; Dlugos D; Miller I; Oh DA; Parikh N; Phillips S; Renfroe JB; Roberts CM; Saeed I; Sparagana SP; Yu J; Cilio MR;
CNS Drugs; 2019 Jun; 33(6):593-604. PubMed ID: 31049885
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience.
Chen KA; Farrar M; Cardamone M; Gill D; Smith R; Cowell CT; Truong L; Lawson JA
Med J Aust; 2018 Aug; 209(5):217-221. PubMed ID: 30092753
[TBL] [Abstract][Full Text] [Related]
11. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
12. Activation patterns of interictal epileptiform discharges in relation to sleep and seizures: An artificial intelligence driven data analysis.
Fürbass F; Koren J; Hartmann M; Brandmayr G; Hafner S; Baumgartner C
Clin Neurophysiol; 2021 Jul; 132(7):1584-1592. PubMed ID: 34030056
[TBL] [Abstract][Full Text] [Related]
13. Factors correlated with intracranial interictal epileptiform discharges in refractory epilepsy.
Quon RJ; Meisenhelter S; Adamovich-Zeitlin RH; Song Y; Steimel SA; Camp EJ; Testorf ME; MacKenzie TA; Gross RE; Lega BC; Sperling MR; Kahana MJ; Jobst BC
Epilepsia; 2021 Feb; 62(2):481-491. PubMed ID: 33332586
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol treatment of severe refractory epilepsy in children and young adults.
Zilmer M; Olofsson K
Dan Med J; 2021 Apr; 68(5):. PubMed ID: 33913416
[TBL] [Abstract][Full Text] [Related]
15. Cognitive correlates of interictal epileptiform discharges in adult patients with epilepsy in China.
Lv Y; Wang Z; Cui L; Ma D; Meng H
Epilepsy Behav; 2013 Oct; 29(1):205-10. PubMed ID: 23994830
[TBL] [Abstract][Full Text] [Related]
16. What is the role of cannabidiol in refractory epilepsy?
LaFleur KM; Nemec EC
JAAPA; 2019 Mar; 32(3):16-18. PubMed ID: 30817475
[TBL] [Abstract][Full Text] [Related]
17. Rapid eye movement sleep affects interictal epileptic activity differently in mesiotemporal and neocortical areas.
Ho A; Hannan S; Thomas J; Avigdor T; Abdallah C; Dubeau F; Gotman J; Frauscher B
Epilepsia; 2023 Nov; 64(11):3036-3048. PubMed ID: 37714213
[TBL] [Abstract][Full Text] [Related]
18. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.
Miller I; Scheffer IE; Gunning B; Sanchez-Carpintero R; Gil-Nagel A; Perry MS; Saneto RP; Checketts D; Dunayevich E; Knappertz V;
JAMA Neurol; 2020 May; 77(5):613-621. PubMed ID: 32119035
[TBL] [Abstract][Full Text] [Related]
19. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
[TBL] [Abstract][Full Text] [Related]
20. Interictal epileptiform discharges have an independent association with cognitive impairment in children with lesional epilepsy.
Glennon JM; Weiss-Croft L; Harrison S; Cross JH; Boyd SG; Baldeweg T
Epilepsia; 2016 Sep; 57(9):1436-42. PubMed ID: 27503785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
